financial guidance Illumina Touts New Partnerships, Sequencing Technology at JP Morgan Healthcare Conference The company's preliminary fourth quarter 2021 revenues grew 25 percent, year over year, while full-year revenues grew 39 percent. Personalis Reports Preliminary Q4 Revenues up More Than 2 Percent The company is expecting continued growth in its oncology orders in Q4 2021 to translate to significant revenue growth for that business next year. Berkeley Lights Preliminary 2021 Revenues Fall Short of Expectations; Firm Searching for New CEO The Emeryville, California-based cell analysis company expects 2021 revenues between $84 million and $84.5 million, a 30 percent year-over-year increase. Agilent Q4 Revenues Rise 12 Percent Revenues for the diagnostics and genomics group increased 16 percent to $341 million from $294 million in the year-ago quarter. NanoString Projects Q4 Instrument Growth; Sees Strong Early Demand for New Spatial Imaging Platform Premium Company executives said that they are seeing high demand for projects involving its forthcoming CosMx spatial molecular imager. Nov 10, 2021 Sophia Genetics Q3 Revenues Increase 44 Percent Nov 9, 2021 NanoString Technologies Q3 Revenues Grow 17 Percent Nov 9, 2021 Veracyte Q3 Revenues Nearly Double Nov 9, 2021 Dermtech Q3 Revenues Rise 122 Percent Nov 8, 2021 Fluidigm Q3 Revenues Drop 29 Percent on Supply Chain Issues, Waning COVID-19 Testing Nov 8, 2021 Castle Biosciences Q3 Revenues Rise 54 Percent Nov 4, 2021 Natera Q3 Revenues Grow 61 Percent Nov 4, 2021 NeoGenomics Q3 Revenues Drop 3 Percent Nov 3, 2021 10x Genomics Q3 Revenues Jump 74 Percent Nov 3, 2021 Qiagen Reports 11 Percent Q3 Revenue Growth; Raises Full-Year Guidance Nov 2, 2021 Exact Sciences Q3 Revenues Rise 12 Percent Nov 1, 2021 Hologic Fiscal Q4 Revenues Fall 2 Percent on Lower COVID-19 Assay Sales Oct 28, 2021 CareDx Q3 Revenues Grow 42 Percent; Firm Discloses Investigations by DOJ, SEC Oct 27, 2021 Thermo Fisher Scientific Q3 Revenues up 9 Percent Oct 21, 2021 BioMérieux Q3 Revenues Increase 11 Percent, Firm Raises 2021 Guidance Oct 21, 2021 Danaher Q3 Revenues Rise 23 Percent, Beat Wall Street Estimates Oct 20, 2021 Roche Diagnostic Revenues Grow 38 Percent in First Nine Months of 2021 on Strong POC Test Sales Sep 17, 2021 Thermo Fisher Scientific Expects 12 Percent Revenue Growth in 2022 Aug 23, 2021 LumiraDx, CA Healthcare Acquisition Revise Merger Terms to Lower Equity Value of Combined Company Aug 23, 2021 SomaLogic Boosts Full-Year 2021 Revenue Guidance by 10 Percent Load More Breaking News New Approach Identifies Candidate Causal Variants for Neuropsychiatric, Neurodevelopmental Conditions People in the News: Baylor's Thomas Caskey Dies; New Appointments at UK Biobank, CS Genetics, More In Brief This Week: Pathogenomix, Uniogen, Genetic Technologies, DnaNudge, Gravity Diagnostics, More New Products Posted to GenomeWeb: Biodesix, Curio Genomics, Akoya Biosciences, More NIH Earmarks $170M for All of Us Program's Personalized Nutrition Study Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable The Scan Omicron's Sewage Path The New York Times writes that testing sewage is helping public health officials track Omicron. IBM Sells Part of Watson Health The Wall Street Journal reports IBM is selling part of its Watson Health business to an investment firm. Identifying the Right Whales The Boston Globe writes that genetic testing has helped identify North American right whales and find that weaning can take place earlier than thought. Science Papers on Approach to Quickly Sort Single Cells, Alternative Splicing in Cancer In Science this week: high-speed sorting of single cells using fluorescence imaging, and more.